VERTEX PHARMACEUTICALS INC / MA Insider Trading for January 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for January 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 187.53 | 1 | 188 | 20,854 | |
Jan 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 237.50 | 1 | 238 | 35,003 | 35 K to 35 K (0.00 %) |
Jan 24 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 187.53 | 1 | 188 | 35,004 | 35 K to 35 K (0.00 %) |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 5,000 | 545,700 | 32,500 | |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 235.00 | 5,000 | 1,175,000 | 36,190 | 41.2 K to 36.2 K (-12.14 %) |
Jan 21 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 5,000 | 545,700 | 41,190 | 36.2 K to 41.2 K (+13.82 %) |
Jan 17 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Option Exercise | A | 0.00 | 200 | 0 | 12,099 | |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 90.29 | 860 | 77,649 | 1,719 | |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 229.38 | 860 | 197,267 | 17,759 | 18.6 K to 17.8 K (-4.62 %) |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 90.29 | 860 | 77,649 | 18,619 | 17.8 K to 18.6 K (+4.84 %) |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 90.29 | 2,125 | 191,866 | 4,250 | |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 228.99 | 300 | 68,697 | 35,003 | 35.3 K to 35 K (-0.85 %) |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 227.56 | 300 | 68,268 | 35,303 | 35.6 K to 35.3 K (-0.84 %) |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 226.42 | 1,225 | 277,365 | 35,603 | 36.8 K to 35.6 K (-3.33 %) |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 225.27 | 300 | 67,581 | 36,828 | 37.1 K to 36.8 K (-0.81 %) |
Jan 15 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 90.29 | 2,125 | 191,866 | 37,128 | 35 K to 37.1 K (+6.07 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Option Exercise | M | 109.14 | 5,000 | 545,700 | 37,500 | |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 230.00 | 5,000 | 1,150,000 | 36,190 | 41.2 K to 36.2 K (-12.14 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Buy | M | 109.14 | 5,000 | 545,700 | 41,190 | 36.2 K to 41.2 K (+13.82 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 131.89 | 13,750 | 1,813,488 | 0 | |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 231.89 | 13,750 | 3,188,488 | 17,759 | 31.5 K to 17.8 K (-43.64 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 131.89 | 13,750 | 1,813,488 | 31,509 | 17.8 K to 31.5 K (+77.43 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Option Exercise | M | 187.53 | 1,675 | 314,113 | 7,263 | |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Sell | S | 227.53 | 1,675 | 381,113 | 7,252 | 8.9 K to 7.3 K (-18.76 %) |
Jan 10 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | SVP, CRO | Buy | M | 187.53 | 1,675 | 314,113 | 8,927 | 7.3 K to 8.9 K (+23.10 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Option Exercise | M | 122.45 | 4,250 | 520,413 | 0 | |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 224.11 | 329 | 73,732 | 35,003 | 35.3 K to 35 K (-0.93 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 223.60 | 1,063 | 237,687 | 35,332 | 36.4 K to 35.3 K (-2.92 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 222.67 | 398 | 88,623 | 36,395 | 36.8 K to 36.4 K (-1.08 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 221.49 | 1,599 | 354,163 | 36,793 | 38.4 K to 36.8 K (-4.16 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 220.69 | 461 | 101,738 | 38,392 | 38.9 K to 38.4 K (-1.19 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Sell | S | 218.93 | 400 | 87,572 | 38,853 | 39.3 K to 38.9 K (-1.02 %) |
Jan 08 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, CL&AO | Buy | M | 122.45 | 4,250 | 520,413 | 39,253 | 35 K to 39.3 K (+12.14 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | M | 72.14 | 20,000 | 1,442,800 | 0 | |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 220.08 | 100 | 22,008 | 9,311 | 9.4 K to 9.3 K (-1.06 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 219.37 | 10,134 | 2,223,096 | 9,411 | 19.5 K to 9.4 K (-51.85 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 218.73 | 7,266 | 1,589,292 | 19,545 | 26.8 K to 19.5 K (-27.10 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 217.72 | 2,500 | 544,300 | 26,811 | 29.3 K to 26.8 K (-8.53 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Buy | M | 72.14 | 20,000 | 1,442,800 | 29,311 | 9.3 K to 29.3 K (+214.80 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 86.52 | 2,427 | 209,984 | 4,045 | |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 90.29 | 2,578 | 232,768 | 2,579 | |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 91.05 | 3,867 | 352,090 | 1,290 | |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Option Exercise | M | 109.14 | 16,758 | 1,828,968 | 0 | |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 220.07 | 100 | 22,007 | 17,759 | 17.9 K to 17.8 K (-0.56 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 219.37 | 12,648 | 2,774,592 | 17,859 | 30.5 K to 17.9 K (-41.46 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 218.70 | 10,040 | 2,195,748 | 30,507 | 40.5 K to 30.5 K (-24.76 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 217.68 | 2,842 | 618,647 | 40,547 | 43.4 K to 40.5 K (-6.55 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 86.52 | 2,427 | 209,984 | 43,389 | 41 K to 43.4 K (+5.93 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 90.29 | 2,578 | 232,768 | 40,962 | 38.4 K to 41 K (+6.72 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 91.05 | 3,867 | 352,090 | 38,384 | 34.5 K to 38.4 K (+11.20 %) |
Jan 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Buy | M | 109.14 | 16,758 | 1,828,968 | 34,517 | 17.8 K to 34.5 K (+94.36 %) |
Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Option Exercise | M | 65.65 | 30,000 | 1,969,500 | 0 | |
Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 221.16 | 300 | 66,348 | 9,311 | 9.6 K to 9.3 K (-3.12 %) |
Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 220.25 | 500 | 110,125 | 9,611 | 10.1 K to 9.6 K (-4.95 %) |
Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 218.93 | 21,798 | 4,772,236 | 10,111 | 31.9 K to 10.1 K (-68.31 %) |
Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Sell | S | 218.05 | 7,402 | 1,614,006 | 31,909 | 39.3 K to 31.9 K (-18.83 %) |
Jan 02 2020 | VRTX | VERTEX PHARMACEUTI ... | YOUNG WILLIAM D | Director | Buy | M | 65.65 | 30,000 | 1,969,500 | 39,311 | 9.3 K to 39.3 K (+322.20 %) |